Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $795 | $591 | $318 | $583 |
| - Cash | $92 | $58 | $251 | $302 |
| + Debt | $6 | $6 | $3 | $1 |
| Enterprise Value | $710 | $540 | $70 | $282 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$104 | -$80 | -$59 | -$26 |
| % Margin | – | – | – | – |
| Net Income | -$86 | -$69 | -$55 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.51 | -1.62 | -1.23 | -0.63 |
| % Growth | 6.8% | -31.7% | -95.2% | – |
| Operating Cash Flow | -$70 | -$50 | -$50 | -$24 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$70 | -$51 | -$51 | -$24 |